10-Q: Health In Tech Reports Strong Q1 2025 Results, Revenue Jumps 56%

Health In Tech's Q1 2025 shows significant revenue growth driven by new product offerings and expanded adoption of self-funded health plan solutions.

Summary

• Health In Tech, Inc. reported its Q1 2025 financial results, showing a 56% increase in revenue compared to Q1 2024.
• Total revenue reached $8.0 million, up from $5.1 million in the prior year.
• The company's growth was fueled by a 17% increase in total billable enrolled employees, reaching 24,307.
• Revenue from underwriting modeling increased by 31.8% to $2.4 million.
• Revenue from fees increased by 69.5% to $5.7 million.
• The company reported a net income of $498,592, compared to $100,536 in Q1 2024.
• Adjusted EBITDA increased to $1.2 million, representing 15.3% of revenue, compared to $0.5 million, or 9.1% of revenue, in the prior year.
• The company is facing a potential revenue reduction from underwriting modeling services due to a carrier's portfolio underperformance, estimating a potential adjustment between $0 and $4.0 million.
• The company is working to cooperate with more stop-loss insurance carriers, it may experience temporary service disruptions in the event the Company deems it necessary to cease use of a stop-loss insurance carrier.

Sentiment

Score: 7

Explanation: The document presents a positive outlook with strong revenue growth and improved profitability. However, the potential revenue reduction and Nasdaq compliance issue introduce some uncertainty.

Positives

• Significant revenue growth of 56% year-over-year.
• Increase in enrolled employees by 17%.
• Improved Adjusted EBITDA margin to 15.3%.
• Strategic collaboration with DialCare enhances service offerings.
• Appointment of Sanjay Shrestha to the Board adds industry expertise.
• The company's accounts receivable turnover period for the three months ended March 31, 2025 was 28 days, remaining stable compared to 29 days for the year ended December 31, 2024.

Negatives

• Potential revenue reduction from underwriting modeling services due to a carrier's portfolio underperformance, estimating a potential adjustment between $0 and $4.0 million.
• Cost of revenues increased as a percentage of revenue, from 19.3% to 33.2%.
• The company is working to cooperate with more stop-loss insurance carriers, it may experience temporary service disruptions in the event the Company deems it necessary to cease use of a stop-loss insurance carrier.

Risks

• Dependence on brokers, TPAs, and other third-party agents for business referrals.
• The company's ability to accurately perform underwriting procedures.
• The company's ability to continue to invest in technology and innovation.
• The company's ability to enter into more collaborations with insurance carriers and offer new products and plans.
• The company's Class A common stock was below the minimum $1.00 per share requirement for continued listing on The Nasdaq Capital Market under Nasdaq Listing Rule 5550(a)(2).

Future Outlook

The company's growth is expected to continue, driven by strong demand for new product offerings and encouraging feedback from ongoing beta testing with mid-to-large employers. The company believes that its cash generated from operating activities will allow it to continue as a going concern at least twelve months from the date of this Quarterly Report on Form 10-Q.

Management Comments

• The company aims to deliver meaningful cost savings for low-risk, small employers with comparatively healthy employees through a digital medical underwriting process.
• The company seeks to deliver time savings for employers, brokers, TPAs, and carriers, by leveraging both external and internally developed technology.

Industry Context

Health In Tech operates in the insurance technology sector, which is experiencing rapid growth due to the increasing demand for digital solutions that streamline processes and improve efficiency in the healthcare industry. The company's focus on providing customizable solutions and leveraging technology to reduce costs positions it well to capitalize on this trend.

Comparison to Industry Standards

• While direct comparisons are difficult due to the unique combination of services offered by Health In Tech, companies like GoHealth and SelectQuote also operate in the health insurance marketplace space.
• However, Health In Tech's focus on self-funded benefits plans and stop-loss insurance for small businesses differentiates it from these larger players.
• The company's Adjusted EBITDA margin of 15.3% is competitive with other high-growth technology companies in the healthcare sector.
• The company's revenue growth of 56% is higher than the average growth rate for the health insurance industry, indicating strong market traction.

Stakeholder Impact

• Shareholders: Positive impact due to revenue growth and improved profitability.
• Employees: Potential positive impact due to company growth and expansion.
• Customers: Potential positive impact due to enhanced service offerings and cost savings.
• Suppliers: Potential positive impact due to increased business volume.

Next Steps

• The company intends to monitor the bid price of its Class A common stock and consider available options if its Class A common stock does not trade at a level likely to result in it regaining compliance with Nasdaq's minimum bid price rule by October 27, 2025.
• The company will continue to assess its historical credit loss experience and consideration of current and expected conditions and market trends (such as general economic conditions, other microeconomic and macroeconomic considerations, etc.) and reasonable and supportable forecasts that could impact the collectability of such receivables over the contractual term individually or in the aggregate.
• The company will quarterly update its estimate to reflect current circumstances until finalized.

Key Dates

Keywords

Health In Tech, financial results, Q1 2025, revenue growth, self-funded health plans, underwriting, Adjusted EBITDA, DialCare, telehealth, insurance technology